This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Name: Jim Hollingshead New title: President and CEO, BVI Previous title: CEO, Insulet Ophthalmic device business BVI has named former Insulet CEO Jim Hollingshead as its next leader, the company said Monday. Hollingshead led Insulet, which sells the Omnipod insulin pump, for three years before resigning in 2025. Ashley McEvoy, the former head of Johnson & Johnson’s ...